Long-term disease stabilization following treatment with erlotinib in heavily pretreated patients with wild-type epidermal growth factor receptor non-small-cell lung carcinoma: Two case reports

Lung adenocarcinomas carrying epidermal growth factor receptor (EGFR) mutations have been identified as a unique group of entities that depend on EGFR for their proliferation and metastasis. The introduction of reversible EGFR tyrosine kinase inhibitors, such as erlotinib, has significantly affected...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Clin Oncol
Hoofdauteurs: Sakellakis, Minas, Koutras, Angelos, Pittaka, Maria, Tsitsopoulos, Efstathios, Kalofonou, Fotini, Kalofonos, Haralabos P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: D.A. Spandidos 2016
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5228472/
https://ncbi.nlm.nih.gov/pubmed/28105360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.1036
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items